Kenya Red Cross Society and Novartis Join Forces

The Kenya Red Cross Society (KRCS) has announced a partnership with Novartis to improve access to prevention, treatment, and care of Non Communicable Diseases (NCDs) in Kenya. As part of the new partnership with Novartis, KRCS will train health workers, community volunteers and scale up screening at community and facility level for NCDs over the next three years.

KRCS will also purchase the Novartis Access portfolio to improve access to NCD prevention, treatment, care and support. KRCS will also focus on thousands of refugees living in the Kakuma and Dadaab refugee camps, as they are facing significant cases of diabetes, hypertension, cancer and asthma.